Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
sub-chronic toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Blood and Brain n-Pentanol in Inhalation Exposure
Author:
Savolainen S, Pfaeffli and Elovaara
Year:
1985
Bibliographic source:
Acta pharmacol et toxicol 56: 260-264
Reference Type:
secondary source
Title:
No information
Author:
RIFM
Year:
2009
Bibliographic source:
RIFM database

Materials and methods

Principles of method if other than guideline:
Analysis of tissue distribution of the test substance in rats after inhalation exposure (with body weight changes evaluation)
GLP compliance:
not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Pentan-1-ol
EC Number:
200-752-1
EC Name:
Pentan-1-ol
Cas Number:
71-41-0
Molecular formula:
C5H12O
IUPAC Name:
pentan-1-ol
Details on test material:
- Name of test material (as cited in study report): n-pentanol
- Analytical purity: analytical grade

Test animals

Species:
rat
Strain:
Wistar
Sex:
male
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 3 months
- Weight at study initiation: 254 ± 29 g for test group, 253 ± 22 g in control group

ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12 / 12

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure:
not specified
Vehicle:
other: unchanged (no vehicle)
Remarks on MMAD:
MMAD / GSD: not given
Details on inhalation exposure:
GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: dynamic chamber (1 m3) technique with continous I.R. control
Analytical verification of doses or concentrations:
not specified
Duration of treatment / exposure:
7 - 14 weeks
Frequency of treatment:
5 days per week, 6 hours daily
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
100, 300, 600 ppm
Basis:
nominal conc.
Remarks:
Doses / Concentrations:
0.36, 1.08, 2.16 mg/l
Basis:
nominal conc.
No. of animals per sex per dose:
10
Control animals:
yes, sham-exposed
Details on study design:
Post-exposure period: none

Examinations

Observations and examinations performed and frequency:
CAGE SIDE OBSERVATIONS: No data

DETAILED CLINICAL OBSERVATIONS: No data

BODY WEIGHT: Yes

FOOD CONSUMPTION: no data

FOOD EFFICIENCY: no data

WATER CONSUMPTION: No data

OPHTHALMOSCOPIC EXAMINATION: No data

HAEMATOLOGY: No data

CLINICAL CHEMISTRY: No data

URINALYSIS: No data

NEUROBEHAVIOURAL EXAMINATION: No data
Sacrifice and pathology:
The tissue distribution of test substance was analysed at necropsy
Other examinations:
- alcohol and aldehyde concentrations in the brain were determined by gas chromatography
- calcium aggregated regated microsomes from liver and kidneys were analyzed for their cytochrome P-450 content
- Cytosolic n-pentanol dehydrogenase activities were also assayed in liver and kidney
Statistics:
The least squares method was used to find out the mathematical relationship of the inhaled and blood n-pentanol concentrations. All results were statistically evaluated with variance analysis.

Results and discussion

Results of examinations

Details on results:
BODY WEIGHT AND WEIGHT GAIN
The weight of the exposed animals did not differ from that of controls at the end of the experiment:
100 ppm: 435 ± 4 g
300 ppm: 397 ± 74 g
600 ppm: 400 ± 34 g
control: 419 ± 29 g

Effect levels

Dose descriptor:
NOAEL
Effect level:
2.16 mg/L air (nominal)
Based on:
test mat.
Sex:
male
Basis for effect level:
other: only body weight data were considered (no changes observed); no additional data provided

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion